|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1997-2-6
|
|
pubmed:abstractText |
Ranitidine bismuth citrate (RBC) is a new chemical entity for the treatment of peptic ulcer disease.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0269-2813
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
10
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
241-50
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:8791946-Animals,
pubmed-meshheading:8791946-Anti-Ulcer Agents,
pubmed-meshheading:8791946-Bismuth,
pubmed-meshheading:8791946-Calorimetry, Differential Scanning,
pubmed-meshheading:8791946-Chemistry, Physical,
pubmed-meshheading:8791946-Drug Combinations,
pubmed-meshheading:8791946-Female,
pubmed-meshheading:8791946-Gastric Acid,
pubmed-meshheading:8791946-Helicobacter pylori,
pubmed-meshheading:8791946-Histamine H2 Antagonists,
pubmed-meshheading:8791946-Humans,
pubmed-meshheading:8791946-Isoenzymes,
pubmed-meshheading:8791946-Magnetic Resonance Spectroscopy,
pubmed-meshheading:8791946-Mice,
pubmed-meshheading:8791946-Mice, Inbred ICR,
pubmed-meshheading:8791946-Organometallic Compounds,
pubmed-meshheading:8791946-Pepsin A,
pubmed-meshheading:8791946-Physicochemical Phenomena,
pubmed-meshheading:8791946-Ranitidine,
pubmed-meshheading:8791946-Solubility,
pubmed-meshheading:8791946-Spectrophotometry, Infrared,
pubmed-meshheading:8791946-X-Ray Diffraction
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Ranitidine bismuth citrate: a novel anti-ulcer agent with different physico-chemical characteristics and improved biological activity to a bismuth citrate-ranitidine admixture.
|
|
pubmed:affiliation |
Glaxo Wellcome Research and Development Ltd, Hertfordshire, UK.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
